Leerink Partners Boosts CVS Health (NYSE:CVS) Price Target to $55.00

CVS Health (NYSE:CVSGet Free Report) had its price target boosted by Leerink Partners from $51.00 to $55.00 in a report released on Tuesday. The firm presently has a “market perform” rating on the pharmacy operator’s stock. Leerink Partners’ price objective would indicate a potential downside of 13.02% from the company’s previous close.

A number of other equities analysts have also weighed in on CVS. TD Cowen upped their target price on CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research report on Monday, November 25th. Evercore ISI upped their price objective on shares of CVS Health from $60.00 to $65.00 and gave the stock an “outperform” rating in a report on Monday, January 27th. Barclays decreased their target price on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research report on Thursday, November 7th. UBS Group dropped their price target on shares of CVS Health from $62.00 to $59.00 and set a “neutral” rating on the stock in a research report on Tuesday. Finally, Truist Financial decreased their price objective on CVS Health from $67.00 to $60.00 and set a “buy” rating for the company in a report on Monday, January 6th. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat.com, CVS Health has a consensus rating of “Moderate Buy” and an average target price of $67.78.

Check Out Our Latest Stock Report on CVS Health

CVS Health Stock Up 15.0 %

CVS Health stock opened at $63.23 on Tuesday. The company has a market capitalization of $79.57 billion, a PE ratio of 16.05, a PEG ratio of 0.60 and a beta of 0.61. CVS Health has a 12-month low of $43.56 and a 12-month high of $80.75. The firm’s fifty day moving average is $50.61 and its 200 day moving average is $55.92. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVSGet Free Report) last announced its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. As a group, sell-side analysts predict that CVS Health will post 5.14 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of CVS. State Street Corp lifted its stake in CVS Health by 3.6% in the third quarter. State Street Corp now owns 56,527,909 shares of the pharmacy operator’s stock valued at $3,554,475,000 after purchasing an additional 1,989,066 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of CVS Health by 2.6% during the 4th quarter. Geode Capital Management LLC now owns 27,051,540 shares of the pharmacy operator’s stock valued at $1,211,582,000 after buying an additional 689,867 shares during the last quarter. Pzena Investment Management LLC grew its stake in shares of CVS Health by 49.3% during the 4th quarter. Pzena Investment Management LLC now owns 19,610,579 shares of the pharmacy operator’s stock worth $880,319,000 after acquiring an additional 6,475,271 shares during the period. Norges Bank purchased a new stake in CVS Health in the 4th quarter worth about $839,574,000. Finally, Charles Schwab Investment Management Inc. lifted its holdings in CVS Health by 5.8% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 12,918,949 shares of the pharmacy operator’s stock valued at $579,932,000 after purchasing an additional 710,281 shares during the last quarter. 80.66% of the stock is owned by institutional investors.

About CVS Health

(Get Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

See Also

Analyst Recommendations for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.